Skip to main content
Clinical Trials/NCT04436341
NCT04436341
Completed
Not Applicable

Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia

Danish Dementia Research Centre2 sites in 1 country50 target enrollmentSeptember 20, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
Danish Dementia Research Centre
Enrollment
50
Locations
2
Primary Endpoint
Epileptic activity in patients with Alzheimer's disease and Lewy body dementia as compared to healthy elderly controls
Status
Completed
Last Updated
last year

Overview

Brief Summary

In the current study, the investigators will examine the extent of subclinical epileptic activity in patients with Alzheimer's disease and patients with Lewy body dementia as compared to healthy elderly controls. The participants will wear a new device called "ear-EEG", which makes it possible to record EEG for longer periods of time while at home. Furthermore, the investigators want to investigate whether there is an association between subclinical epileptic activity and the cerebral blood flow as measured with functional MRI.

Registry
clinicaltrials.gov
Start Date
September 20, 2019
End Date
June 1, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Danish Dementia Research Centre
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Epileptic activity in patients with Alzheimer's disease and Lewy body dementia as compared to healthy elderly controls

Time Frame: 2 years

Compare the prevalence and type of paroxysmal activity as measured with the ear-EEG in patients with Alzheimer's disease and Lewy body dementia as compared to healthy elderly controls

Feasibility study: Investigate whether patients with Alzheimer's disease are able wear ear-EEG for longer than 24 hours during a 48 hours period

Time Frame: 8 months

If it is possible for patients with Alzheimer's disease to wear ear-EEG for at least 24 hours including 5 hours of sleep during a 48 hours period

Study Sites (2)

Loading locations...

Similar Trials